Causaly

Causaly

Private
London, EnglandHealthcare & Life Scienceshttps://www.causaly.com

Last Round

Series B

Jul 13, 2023

Total Funding Raised

$82.8M

Company Overview

Causaly is a biomedical technology company that offers a platform for uncovering evidence, exploring hidden connections, and generating new predictions in biomedical science, significantly speeding up the research process by enabling deep searches for complex questions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Vertical SaaS, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

drug discovery AIcausal AIbiomedical knowledge graphlife sciences AIagentic AItarget identificationdrug discoverybiomarker discoveryAI copilotpreclinical researchpharma AIknowledge graphnatural language processingcompetitive intelligenceknowledge graph APIdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Causaly Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Causaly Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJul 13, 2023
Series AMay 19, 2021
Series ANov 19, 2019
SeedJul 26, 2018

Key People

Founding team and executive leadership

Artur Saudabayev

Co-Founder, CTO

Founding Team

Marco Costa

Chief Operating Officer

Executive Team

Causaly Investors

Notable investors and investment history

InvestorRounds
ICONIQ GrowthSeries B
Visionaries ClubSeries B
Marathon Venture CapitalSeries A, Series B, Seed
EmergeSeed
European Bank for Reconstruction and DevelopmentSeries A, Series B
Index VenturesSeries B, Series A
PentechSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 8, 2026

    Added L’Oréal Group as a customer.

  • Mar 8, 2026

    Added Lupin Pharmaceuticals as an enterprise customer.

Causaly Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Causaly Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Causaly's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range135
Year Founded2017
Last FundingJul 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.